Bone Marrow Failure due to Aplastic Anemia, Associated With Serous Fat Atrophy, and Treated With Allogeneic, Haploidentical Stem Cell Transplantation: A Case Report

We describe the case of a 27-year-old male, previously healthy though with a social history notable for recreational cocaine use, who developed bone marrow failure due to aplastic anemia (AA) with associated serous fat atrophy (SFA). After the SFA was corrected with nutritional supplementation, the...

Full description

Saved in:
Bibliographic Details
Main Authors: Matthew J. Pisarcik, Cameron J. Oswalt, Eric D. Carlsen, Mitchell E. Horwitz
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/crh/6526961
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850162722238365696
author Matthew J. Pisarcik
Cameron J. Oswalt
Eric D. Carlsen
Mitchell E. Horwitz
author_facet Matthew J. Pisarcik
Cameron J. Oswalt
Eric D. Carlsen
Mitchell E. Horwitz
author_sort Matthew J. Pisarcik
collection DOAJ
description We describe the case of a 27-year-old male, previously healthy though with a social history notable for recreational cocaine use, who developed bone marrow failure due to aplastic anemia (AA) with associated serous fat atrophy (SFA). After the SFA was corrected with nutritional supplementation, the patient underwent successful allogeneic, haploidentical stem cell transplantation with a regimen designed to treat AA. To our knowledge, this is the first case of hematopoietic stem cell transplantation (HSCT) performed following correction of SFA. Herein we propose our novel hypothesis that SFA, once resolved, is not a contraindication to stem cell transplantation, which we believe adds valuable insight toward an improved understanding of nutrition’s role in HSCT. Additionally, the AA is thought to be toxin-induced and specifically levamisole-mediated after exposure to levamisole-adulterated cocaine. We highlight potential connections between levamisole, AA, and SFA and call for further efforts to understand these relationships—especially as the use of levamisole as a cocaine adulterant continues to rise across the globe.
format Article
id doaj-art-a0163daffc3149459b0b8cf7a7dc6272
institution OA Journals
issn 2090-6579
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-a0163daffc3149459b0b8cf7a7dc62722025-08-20T02:22:29ZengWileyCase Reports in Hematology2090-65792024-01-01202410.1155/crh/6526961Bone Marrow Failure due to Aplastic Anemia, Associated With Serous Fat Atrophy, and Treated With Allogeneic, Haploidentical Stem Cell Transplantation: A Case ReportMatthew J. Pisarcik0Cameron J. Oswalt1Eric D. Carlsen2Mitchell E. Horwitz3Division of Medical OncologyDuke Cancer InstituteDuke Cancer InstituteDuke Cancer InstituteWe describe the case of a 27-year-old male, previously healthy though with a social history notable for recreational cocaine use, who developed bone marrow failure due to aplastic anemia (AA) with associated serous fat atrophy (SFA). After the SFA was corrected with nutritional supplementation, the patient underwent successful allogeneic, haploidentical stem cell transplantation with a regimen designed to treat AA. To our knowledge, this is the first case of hematopoietic stem cell transplantation (HSCT) performed following correction of SFA. Herein we propose our novel hypothesis that SFA, once resolved, is not a contraindication to stem cell transplantation, which we believe adds valuable insight toward an improved understanding of nutrition’s role in HSCT. Additionally, the AA is thought to be toxin-induced and specifically levamisole-mediated after exposure to levamisole-adulterated cocaine. We highlight potential connections between levamisole, AA, and SFA and call for further efforts to understand these relationships—especially as the use of levamisole as a cocaine adulterant continues to rise across the globe.http://dx.doi.org/10.1155/crh/6526961
spellingShingle Matthew J. Pisarcik
Cameron J. Oswalt
Eric D. Carlsen
Mitchell E. Horwitz
Bone Marrow Failure due to Aplastic Anemia, Associated With Serous Fat Atrophy, and Treated With Allogeneic, Haploidentical Stem Cell Transplantation: A Case Report
Case Reports in Hematology
title Bone Marrow Failure due to Aplastic Anemia, Associated With Serous Fat Atrophy, and Treated With Allogeneic, Haploidentical Stem Cell Transplantation: A Case Report
title_full Bone Marrow Failure due to Aplastic Anemia, Associated With Serous Fat Atrophy, and Treated With Allogeneic, Haploidentical Stem Cell Transplantation: A Case Report
title_fullStr Bone Marrow Failure due to Aplastic Anemia, Associated With Serous Fat Atrophy, and Treated With Allogeneic, Haploidentical Stem Cell Transplantation: A Case Report
title_full_unstemmed Bone Marrow Failure due to Aplastic Anemia, Associated With Serous Fat Atrophy, and Treated With Allogeneic, Haploidentical Stem Cell Transplantation: A Case Report
title_short Bone Marrow Failure due to Aplastic Anemia, Associated With Serous Fat Atrophy, and Treated With Allogeneic, Haploidentical Stem Cell Transplantation: A Case Report
title_sort bone marrow failure due to aplastic anemia associated with serous fat atrophy and treated with allogeneic haploidentical stem cell transplantation a case report
url http://dx.doi.org/10.1155/crh/6526961
work_keys_str_mv AT matthewjpisarcik bonemarrowfailureduetoaplasticanemiaassociatedwithserousfatatrophyandtreatedwithallogeneichaploidenticalstemcelltransplantationacasereport
AT cameronjoswalt bonemarrowfailureduetoaplasticanemiaassociatedwithserousfatatrophyandtreatedwithallogeneichaploidenticalstemcelltransplantationacasereport
AT ericdcarlsen bonemarrowfailureduetoaplasticanemiaassociatedwithserousfatatrophyandtreatedwithallogeneichaploidenticalstemcelltransplantationacasereport
AT mitchellehorwitz bonemarrowfailureduetoaplasticanemiaassociatedwithserousfatatrophyandtreatedwithallogeneichaploidenticalstemcelltransplantationacasereport